Vorinostat Completed Phase 1 Trials for Metastatic Brain Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00838929Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases